Proposed initiative would seek to create an issuer-authorized, blockchain-based representation of Myseum.AI common stock while preserving traditional shareholder rights

NEW BRUNSWICK, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Myseum.AI, Inc. (Nasdaq: MYSE) (“Myseum.AI” or the “Company”), a privacy-first agentic AI and social media technology company, today announced that it intends to apply to tokenize its Nasdaq-listed common stock through one or more qualified digital-asset securities platforms.

The planned application follows significant regulatory developments supporting the introduction of blockchain-based representations of publicly traded equities in the United States. Myseum.AI intends to evaluate an issuer-authorized structure in which tokenized Myseum.AI shares would represent the Company’s actual registered common stock, not synthetic exposure, and would be designed to preserve the economic, voting and other ownership rights associated with traditional Myseum.AI shares. The announcement does not constitute the issuance of a new security, a change in the Company’s existing capital structure or an offer to sell securities. Myseum.AI’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “MYSE.” Existing shareholders are not required to take any action at this time.

If approved and successfully implemented, tokenization could allow eligible investors to hold and transfer a digital representation of Myseum.AI common stock using blockchain infrastructure, subject to applicable securities laws, trading-platform requirements and geographic restrictions.

Potential benefits under evaluation include:

  • Expanded access to Myseum.AI shares through digital native investment platforms.
  • Greater transparency through blockchain-based ownership records.
  • More efficient trade settlement and share transfers.
  • Potential access to extended hours or continuous trading environments where legally permitted.
  • Improved interoperability between traditional securities and regulated digital-asset infrastructure.
  • Broader engagement with a new generation of global and digitally native investors.

“Tokenization has the potential to fundamentally modernize how public-company shares are held, transferred and accessed,” said Darin Myman, Chief Executive Officer of Myseum.AI. “We believe Myseum.AI has an opportunity to move decisively as regulated capital markets begin adopting blockchain infrastructure.”

“Our objective is not to create a synthetic instrument that merely tracks Myseum.AI’s market price,” Myman continued. “We intend to explore an issuer-supported structure designed to represent actual ownership of Myseum.AI common stock and preserve the rights of our shareholders. We believe this distinction is essential to building a transparent, compliant and credible tokenized-equity program.”

The Company plans to begin discussions with regulated tokenization platforms, broker-dealers, transfer agents, custodians and other digital-securities infrastructure providers. The Company will evaluate potential blockchain networks and service providers based on regulatory compliance, cybersecurity, investor protection, market accessibility, scalability and compatibility with Myseums.ai’s existing Nasdaq listing.

Any tokenization would be subject to completion of the Company’s evaluation process, acceptance by a qualified provider or trading platform, applicable regulatory and exchange requirements, and the negotiation of definitive agreements. There can be no assurance that the application will be accepted or that tokenized trading of Myseum.AI common stock will ultimately become available.

About Myseum.AI, Inc.

Myseum.AI (formerly DatChat, Inc.) is a privacy-focused AI and social media technology company developing innovative platforms for secure digital sharing and storage. Its flagship platform, Picture Party, is a next-generation patented instant social networking experience designed to make sharing photos easier, more fun, and more private. The platform enables users to create curated albums, build encrypted galleries with controlled access, personalize their content feeds, and organize collections within a broader digital ecosystem. Picture Party by Myseum.AI is currently available at the iOS App Store and Google Play, with a desktop version expected later this year. For more information, visit myseum.com.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC’s website at www.sec.gov. Except as may be required by applicable law, the Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact
ir@datchats.com
732-374-3529

ROCKVILLE, Md., Sept. 23, 2026 (GLOBE NEWSWIRE) — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has appointed Sidharth Kapileshwar as Chief Corporate Development Officer.

“Sidharth has a proven track record of building and scaling corporate development functions inside some of the largest healthcare companies in the world. He knows firsthand what it takes to translate strategy into growth,” said Maher Masoud, President and Chief Executive Officer. “I am confident that Sidharth’s expertise will support MaxCyte’s next chapter of growth.”

Mr. Kapileshwar joins MaxCyte from Danaher Corporation, where he most recently served as Vice President of Innovation for the company’s Life Sciences Platform, leading enterprise-wide innovation programs. Over nearly 25 years, he has held corporate development, strategy, innovation, and M&A leadership roles at global life sciences and technology companies, including GE Healthcare, Beckman Coulter, and Halma plc. Mr. Kapileshwar holds a Master of Science in Engineering from The Ohio State University, an MBA from the University of Chicago Booth School of Business, and a Bachelor of Technology in Engineering from the Indian Institute of Technology Bombay.

“MaxCyte has been an early pioneer in applying flow electroporation at clinical and commercial scale for cell and gene therapies, and its technologies are foundational to where the field is headed. That’s exactly the kind of opportunity I want to help build at MaxCyte,” said Sidharth Kapileshwar. “I’ve spent my career helping large, global organizations sharpen their strategies and execute their next phase of growth, and I’m excited to bring that same momentum to MaxCyte.”

About MaxCyte

At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure DX™ gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping the future of medicine. Learn more at maxcyte.com and follow us on X and LinkedIn.

MaxCyte Contacts:

Investor Relations
Gilmartin Group
Erik Abdow
ir@maxcyte.com

Media Contact
Oak Street Communications
Kristen White
+1 415-608-6060
kristen@oakstreetcommunications.com

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — SPARC AI Inc. (CSE: SPAI; OTCQB: SPAIF; Frankfurt: 5OV0) (“SPARC AI” or the “Company”), a defense technology company delivering positioning in GPS-denied environments, today announced the completion of a three-week customer tour of Ukraine following the International Defence Industry Exhibition (MSPO) in Kielce, Poland, where the Company launched Overwatch Patrol.

The tour opened with a series of private events attended by more than a dozen drone OEMs and operators, where SPARC AI showcased the Overwatch Positioning Network and launched Overwatch Intelligence. Overwatch Intelligence is a premium module for intelligence, surveillance and reconnaissance (ISR) missions in GPS-denied conditions. It turns what a drone sees into georeferenced intelligence, allowing operators to extract target coordinates from live or recorded imagery with no GPS on the aircraft. Operators can click on any pixel in an image to obtain the location coordinates of a target.

The team then travelled to several polygons (military test ranges) for live demonstrations with drone manufacturers before heading east to within 17 km of the front line. There, Overwatch was integrated on site into a large quadcopter and deployed in a GPS-jammed environment, where the team completed a series of flights obtaining aircraft position and target coordinates without satellite navigation. In one demonstration, the aircraft recorded the precise location of a pole more than 600 metres away with no GPS, no laser rangefinder and no additional hardware on the aircraft.

The tour also demonstrated the speed of the Overwatch Positioning Network under battlefield conditions. Telemetry from the drone was sent to Overwatch and latitude and longitude were returned in milliseconds, confirming the service can deliver positioning in a contested environment with no compute or software on the aircraft. No telemetry or position data is stored by Overwatch.

Overwatch Patrol, the Company’s dismounted positioning service launched at MSPO, was also demonstrated during the tour. In one demonstration under GPS interference, the device’s satellite-derived position placed the user several kilometres from their actual location, while Overwatch Patrol displayed the correct position with no GPS and no additional hardware.

Ukraine remains the most demanding operating environment in the world for drone technology, and the tour allowed SPARC AI to demonstrate Overwatch to new OEMs and operators flying daily under electronic warfare conditions.

Prior to Poland and Ukraine, the team demonstrated Overwatch in a Western-aligned partner nation in the Middle East under similar GPS-jamming conditions. There, Overwatch successfully obtained the aircraft’s position without satellite navigation and then generated target coordinates through the Overwatch Positioning Network – the same self-locate to target-locate sequence later flown near the front line in Ukraine.

Following these deployments, the Company is engaged with several drone OEMs on existing and new opportunities, with Overwatch proven to operate in highly contested and GPS-jammed environments. These engagements include extending Overwatch’s capability to unmanned ground vehicles (UGVs) and fixed-wing platforms. The Company is also in the process of obtaining a NATO Stock Number (NSN) for Overwatch, which would enable the product to be catalogued and procured through NATO and allied defense supply systems. The Company expects to provide further updates as these engagements progress.

About SPARC AI Inc.
SPARC AI is a defense technology company solving navigation in GNSS-denied environments. Its flagship product, Overwatch, is a platform that ingests telemetry from drones and other moving platforms and returns absolute latitude and longitude — no onboard software, no edge hardware, and no reliance on GPS. Delivered as a stateless service, Overwatch gives commercial and defense operators dependable positioning wherever satellite signals are jammed, spoofed, or unavailable.

Cautionary Statement Regarding Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws and may also constitute “forward-looking statements” within the meaning of United States securities laws (collectively, “forward-looking statements”). Forward-looking statements in this release include, but are not limited to, statements regarding the use of proceeds from the completed financing, the Company’s future, R&D programs, development activities, and the potential of its technology. Forward-looking statements are based on the current expectations, estimates, beliefs and assumptions of management as of the date hereof. Such statements are subject to several known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the use of proceeds, market conditions, competition, development activities, pricing, and general economic conditions. Although the Company believes that the assumptions and expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT: For further information contact:
SPARC AI Inc.
E-mail: investors@sparcai.com
Web: www.sparcai.com
Tel: (213) 459-3994

Transaction in Own Shares

September 22, 2026

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 22 September 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of Purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency
22/09/2026 900,000 £ 35.2300 £ 34.4500 £ 34.8883 LSE GBP
22/09/2026 150,000 £ 35.1650 £ 34.4600 £ 34.8434 Chi-X (CXE) GBP
22/09/2026 – – – – BATS (BXE) GBP
22/09/2026 500,000 € 41.1550 € 40.2250 € 40.7185 XAMS EUR
22/09/2026 – – – – CBOE DXE EUR
22/09/2026 – – – – TQEX EUR

These share purchases form part of the on- and off-market limbs of the Company’s existing share buy-back programme previously announced on 30 July 2026.

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

Attachment

Paychex WISE Hire

WISE Hire offers multi-channel candidate sourcing, recruiting workflow automation, candidate matching support, and hiring expertise to help businesses hire more effectively.
WISE Hire offers multi-channel candidate sourcing, recruiting workflow automation, candidate matching support, and hiring expertise to help businesses hire more effectively.

New solution enhances multi-channel candidate sourcing, recruiting workflow automation, candidate matching support, and hiring expertise to help businesses hire faster while maintaining decision-making authority 

  • Paychex launches AI-agent platform built for front-line workers to help customers hire more quickly and effectively
  • Solution is available as both a standalone offering and integrated within Paychex’s HCM platforms
  • WISE Hire is accessible through WISE, the company’s AI engine spanning embedded intelligence, personal assistants, and AI agents

ROCHESTER, N.Y., Sept. 23, 2026 (GLOBE NEWSWIRE) — Paychex (Nasdaq: PAYX), a leading provider of expert-enabled HR, payroll, and benefits, today introduced WISE Hire, an AI-native recruiting solution that helps businesses find and hire qualified talent 4x faster on average. Available standalone or integrated within Paychex’s HCM platforms, WISE Hire combines AI agents for digital candidate sourcing, recruiting, and hiring coaching. The result is an automated experience that maintains strong governance, human-in-the-loop oversight, and customer control of hiring decisions.

Paychex research consistently shows attracting and recruiting talent is one of the most significant challenges a business faces – and business leaders spend more than one-third of their time on administrative hiring tasks.

“Offering solutions that help our customers solve some of their most pressing challenges, such as recruiting and hiring, is core to our product strategy,” said Ryan Bergstrom, Chief Product and Technology Officer at Paychex. “WISE Hire expands on our existing capabilities, empowering businesses to fill positions faster by automating routine hiring tasks while keeping people at the center of every hiring decision.”

Expanding WISE with Embedded AI Recruiting Automation and Expertise
WISE Hire will help businesses fill vacancies quickly and effectively by embedding recruiting workflow automation, candidate matching support, and hiring expertise in WISE, Paychex’s AI engine across its HCM platforms — SurePayroll, Paychex Flex®, and Paycor®. Whether used integrated or standalone, the AI-powered technology is designed to automate routine workflows such as sourcing, screening, coordination, and scheduling, while a patented candidate-matching technology and network of hiring coaches pairs automation with human expertise.

Broad Candidate Reach, Smarter Recruiting Workflows, and Human-Led Hiring Decisions
WISE Hire can also access industry-leading worker acquisition channels such as Google for Jobs, Meta’s local jobs marketplace, and ChatGPT to enhance candidate sourcing. Employers retain responsibility for evaluating candidates and making hiring decisions, with human oversight incorporated throughout the recruiting workflow. WISE Hire will help new and existing customers attract, screen, and engage candidates more efficiently and effectively, while maintaining human oversight and decision-making authority.

Advancing the Future of Hiring Through Intelligent Workforce Technology
While WISE Hire is integrated across Paychex’s HCM platforms, the solution is also available standalone. The latest demonstration of the company’s ongoing commitment to delivering innovative, AI-driven solutions to help customers solve workforce challenges and achieve better business outcomes. Combining WISE intelligence with AI-powered hiring capabilities, Paychex is making it easier for businesses of all sizes to find, hire, and retain the right talent faster.

To learn more about WISE Hire, along with Paychex’s full suite of expert-enabled technology and advisory solutions, visit the Paychex booth (#4227) at the HR Technology Conference & Expo at Mandalay Bay in Las Vegas, Oct. 20-22, 2026.

About Paychex
Paychex, Inc. (Nasdaq: PAYX) provides a comprehensive suite of expert-enabled technology and advisory solutions that help businesses manage HR, payroll, and benefits. Serving approximately 840,000 customers and paying 1 in 11 U.S. private sector workers, Paychex combines scale, trusted expertise, and innovation to help businesses succeed. Built on more than 50 years of workforce experience and one of the industry’s largest proprietary HR datasets, Paychex’s WISE agentic AI engine embeds intelligence directly into workflows to improve productivity, enhance decision-making, and deliver better outcomes. Learn more at paychex.com.

Media Contact
Tracy Volkmann
Manager, Public Relations
Paychex, Inc.
(585) 657-7336
tvolkmann@paychex.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/805fb418-499b-4ce9-bffa-42d4f10dad14

Viasat selected to provide integrated, multi-network services as part of an end-to-end solution to address USMC mission performance and resiliency requirements

CARLSBAD, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) — Viasat Inc. (NASDAQ: VSAT), a global leader in satellite communications (SATCOM), today announced it was awarded, through its subsidiary Inmarsat Government, Inc., the Marine Enterprise Commercial Satcom Satellite Services (MECS2) contract from the U.S. Space Force Commercial Satellite Communications Office (CSCO). Viasat has received an initial $42 million task order award under what is a seven-year, up to $307 million ceiling Indefinite Delivery/Indefinite Quantity (IDIQ) contract through which Viasat will provide fully managed, end-to-end global satellite services for the United States Marine Corps (USMC).

The award builds on Viasat’s history of providing managed SATCOM services to the USMC, as well as continued access to a global, resilient terrestrial network for secure data transport. Viasat’s government SATCOM team, under the company’s Communication Services segment, will deliver global satellite connectivity services across L-, Ku, and Ka-bands through flexible terminal solutions and satellites across orbits from Viasat and its ecosystem partners. These services are designed to support USMC communications and mission requirements with reliable and secure connectivity for multi-domain operations across land, air and sea.

As part of its commitment to delivering a fully integrated solution, Viasat has teamed with multiple providers to enable resilient, high-capacity and multi-orbit connectivity with a cost-effective structure that can scale to support a wide range of mission applications. This service will provide access to Viasat’s integrated global Ka-band network, which includes the next-generation ViaSat-3 satellites for ultra-high-capacity and the flexibility to quickly direct capacity to high-concentration activity hotspots.

“We’re extremely proud the Marine Corps has selected Viasat to continue as its trusted partner for enterprise, multi-orbit SATCOM services,” said Victor Farah, Senior Vice President of Government Solutions and Services. “Our team is committed to delivering an information advantage through flexible, high-performance and secure connectivity that will support the communications demands of rapidly evolving and expeditionary operations.”

Viasat will provide secure data custody from the edge back to the Marine Corps Enterprise Network via Viasat’s worldwide terrestrial network. The fully managed Viasat service will also include 24x7x365 Network Operations Center (NOC) and Security Operations Center (SOC) support to provide the USMC with bandwidth management, terminal inventory management, network performance monitoring and cybersecurity services.

“In the modern warfare environment, there is a critical need to maintain information dominance across the battlespace. We are excited to continue supporting this objective by providing a comprehensive enterprise solution that leverages Viasat’s expertise and ecosystem to meet current USMC technology needs, as well as the ability to scale with new, integrated technologies and platform capabilities for the future,” said Qasim Rana, Vice President of Market Entry for Government.

Visit the Viasat website for more information on the flexible SATCOM services for multi-domain operations.

About Viasat 
Viasat is a global technology company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people’s lives anywhere they are—on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on LinkedIn, X, Instagram, Facebook, Bluesky, Threads, and YouTube. 

Copyright © 2026 Viasat, Inc. All rights reserved. Viasat, the Viasat logo and the Viasat Signal are registered trademarks in the U.S. and in other countries of Viasat, Inc. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners.

Viasat, Inc. Contacts
Dan Bleier, Public Relations, Corporate and Government, +1 (202) 383-5074, daniel.bleier@viasat.com
Lisa Curran/Pete Lopez, Investor Relations, +1 (760) 476-2633, IR@viasat.com

Forward-Looking Statements
This press release contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933 and the Securities Exchange Act of 1934. Forward-looking statements include, among others, statements about the receipt of awards under the IDIQ contract; the services, features, benefits and performance of Viasat’s fully managed, enterprise satellite communication services for U.S. Marine Corps; the coverage, flexibility and capacity of ViaSat-3 satellites; and the effect of adverse regulatory changes. Readers are cautioned that actual results could differ materially and adversely from those expressed in any forward-looking statements. Factors that could cause actual results to differ include: risks associated with the construction, launch and operation of satellites, including the effect of any anomaly, operational failure or degradation in satellite performance; the integration of third-party provider services; contractual problems, product defects, manufacturing issues or delays, regulatory issues, technologies not being developed according to anticipated schedules, or that do not perform according to expectations; and increased competition and other factors affecting the defense sector generally. In addition, please refer to the risk factors contained in Viasat’s SEC filings available at www.sec.gov, including Viasat’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. Viasat undertakes no obligation to update or revise any forward-looking statements for any reason.

The September run processed approximately 758 kilograms of polymer, with consistent product quality and a return to target operating conditions approximately two hours sooner than the comparable prior run. NGP operating data continue to be used as part of Early Works engineering for the FOAK Program at Chemelot.

LONDON, Ontario, Sept. 23, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today provided an update on continued progress in the operating campaign program at its Next Generation Process (“NGP”) Pilot Plant.

Highlights

  • Repeatability across successive campaigns: Multiple NGP campaigns conducted through July, August, and September have demonstrated progressive improvement in NGP process control and operation, while maintaining consistent process and product performance across different feed compositions and operating parameters.
  • Mixed-polyolefin performance: During the September campaign, condensable hydrocarbon yield was 88.8% with 100% polypropylene (“PP”), 90.8% with an 80:20 PP/polyethylene (“PE”) blend, and 89.2% with a 50:50 PP/PE blend. Condensable hydrocarbon yield represents the recovered liquid and waxy hydrocarbon product and excludes non-condensed hydrocarbon gases. Results were consistent with the objectives of the campaign.
  • Latest campaign: The September campaign ran for 75 hours and processed approximately 758 kilograms of polymer across three controlled polyolefin feed compositions.
  • Consistent product quality and improving process control: Product-quality indicators remained consistent with prior campaign results, and the system returned to target operating conditions approximately two hours sooner than in the comparable prior run following changes in process conditions.
  • Iterative engineering: Operating findings are being used to refine equipment, instrumentation, controls, and operating procedures, with modifications implemented between campaigns and evaluated in subsequent runs.
  • Direct FOAK integration: NGP operating data continue to be used as part of Early Works engineering and procurement activities for the First-of-a-Kind (“FOAK”) Program at Chemelot.
  • Next stage: The NGP program is expected to progress to longer campaigns using waste-plastic materials supplied by prospective FOAK feedstock partners, including feedstocks with broader compositional characteristics increasingly representative of those being evaluated for the FOAK Plant.

The latest September campaign extended this work over a longer operating period, progressing from the established PP operating reference to progressively higher PE content while maintaining product-quality indicators consistent with prior campaign results. Condensable hydrocarbon yield was 88.8% on 100% PP, 90.8% on the 80:20 PP/PE blend, and 89.2% on the 50:50 PP/PE blend.

Changes in PP/PE feed composition require timely adjustments to operating parameters. Successive campaigns are defining these relationships while demonstrating the ability to continue operation, maintain process control, and restore target operating conditions as feed composition changes. In the latest campaign, the system returned to target conditions approximately two hours sooner than in the comparable prior run, providing a measurable indication of continued improvement in process control and operating procedures.

Controlled PP/PE blends allow Aduro to isolate how changes in feed composition affect process conditions and system response before progressing to more complex waste-plastic feedstocks relevant to chemical recycling in Europe. Future testing is expected to extend across the broader PP/PE composition range, including an 80:20 PE/PP blend.

The NGP Pilot Plant integrates industrial equipment and process controls at pilot scale. Between campaigns, Aduro reviews operating and analytical data, evaluates equipment and instrumentation performance, and implements engineering and operating improvements identified through testing. Subsequent campaigns are then used to evaluate those changes under operating conditions. This iterative approach allows operating constraints to be identified and addressed at pilot scale while continuing to evaluate Hydrochemolytic™ Technology (“HCT”) reactor chemistry, product performance, and integrated system operation, building practical knowledge relevant to the design and operation of the FOAK Plant.

In parallel, Saipem S.p.A. (“Saipem”) is advancing Early Works engineering and procurement activities for Aduro’s FOAK Program at Chemelot. The scope includes review of the Process Design Package, optimization of critical equipment packages, preliminary utility integration, and refinement of capital cost estimates. Saipem is already receiving operating data generated through the NGP Pilot Plant, providing a direct path for Pilot Plant observations and validated improvements to inform the engineering basis for the FOAK Plant.

“Successive NGP campaigns are strengthening our understanding of both the chemistry and the operation of the integrated system,” said Ofer Vicus, Chief Executive Officer at Aduro. “As feed composition changes, our Operations team continues to develop a deeper understanding of how to adjust process conditions and return the system to target operating conditions while maintaining consistent product performance. The progress we are seeing reflects their work in building practical operating knowledge around a pilot-scale system that integrates industrial equipment and process controls. With Saipem already receiving NGP operating data, those learnings are directly informing development of the engineering basis for the FOAK Plant.”

The next stage of the NGP program is expected to include longer campaigns using more complex waste-plastic materials, including prospective FOAK feedstocks and selected materials arising through Aduro’s Customer Engagement Program. This progression moves testing beyond controlled PP/PE blends and broadens the operating dataset across feedstocks relevant to both FOAK development and future application testing.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development / Investor Relations
ir@adurocleantech.com
+1 226 784 8889

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of applicable Canadian and United States securities laws.

Forward-looking statements include, but are not limited to, statements concerning continued operation and progression of campaigns at the NGP Pilot Plant; planned longer-duration operating campaigns; evaluation of additional PP/PE feed compositions and waste-plastic materials; evaluation of waste-plastic materials supplied by prospective feedstock partners for the FOAK project; potential evaluation of materials arising through the Company’s Customer Engagement Program; interpretation and use of Pilot Plant operating, condensable hydrocarbon yield, product-quality, and process-control data; the ability to reproduce and extend operating results across different feedstocks and process conditions; implementation and evaluation of engineering and operating improvements identified through Pilot Plant testing; incorporation of NGP operating data into the engineering basis for the planned FOAK Plant; development, design, engineering, financing, procurement, construction, commissioning, and start-up of the FOAK Plant and broader FOAK Facility at Chemelot; the scope and progression of Early Works activities with Saipem; and the Company’s broader scale-up and commercialization pathway.

Forward-looking statements are based on management’s current expectations, estimates, assumptions, and projections, including assumptions relating to continued performance and availability of the NGP Pilot Plant; the ability to reproduce and extend operating results; the ability to conduct longer campaigns and evaluate additional feedstocks; the applicability of Pilot Plant data to larger-scale engineering and operation; successful completion and progression of Early Works activities with Saipem; the availability and suitability of feedstocks supplied by prospective partners; the availability of suitable personnel, partners, contractors, equipment, and capital; the ability to obtain required permits and regulatory approvals; and stable market, regulatory, and economic conditions.

Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied. These risks include operational challenges or delays in Pilot Plant campaigns; variability in feedstock composition, recovery, product quality, or process stability; the possibility that results observed in individual campaigns may not be reproduced under different conditions or at larger scale; challenges in translating Pilot Plant data into engineering design; delays, changes in scope, or cost increases affecting FOAK Plant engineering, financing, procurement, construction, commissioning, or start-up; the possibility that the Saipem engagement may not progress beyond the Early Works phase; inability to establish or maintain feedstock, commercial, technical, or development relationships; the possibility that testing programs may not produce results supporting further development; supply-chain constraints; competition; intellectual-property risks; availability and cost of capital; and other risks described in the Company’s public filings available on SEDAR+ at www.sedarplus.ca and on EDGAR through the U.S. Securities and Exchange Commission at www.sec.gov.

Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are made as of the date of this release, and the Company undertakes no obligation to update or revise them except as required by applicable law.

Aduro - Pilot Plant Update PR

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/61267443-a33c-4376-8dc6-0be1478c40a6

HP TV+ adopts Magnite’s full-stack technology, including SpringServe ad serving, programmatic activation, and ClearLine Curation

NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced it is the primary video ad server and a programmatic technology provider for HP TV+, providing access to programmatic demand across HP TV+ banner and video inventory.

By tapping into Magnite’s omnichannel suite, HP TV+ can seamlessly connect advertisers with active PC audiences across trusted programming categories spanning movies, live sports, lifestyle, news, and specialized content. As part of HP Media Network, HP TV+ is HP’s native free ad-supported streaming TV (FAST) environment designed specifically for personal PCs. HP TV+ delivers a personal, 1:1 streaming experience that bridges entertainment and active online behavior allowing users to watch, research, shop, and act on a single screen.

Through ClearLine Curation, HP Media Network can make its consent-based audience intelligence more accessible for programmatic activation, giving buyers a streamlined way to reach audiences informed by real PC behavior. Buyers can activate nearly 100 off-the-shelf audience segments or define custom segments built from insights across 1,200 PC apps and 300+ consent-based usage attributes.

“PC-native streaming introduces a powerful dynamic where viewing, research, and action occur simultaneously on the exact same device,” said Chris Signore, Senior Vice President, Business Development at Magnite. “Streaming on a personal PC offers a highly connected environment where entertainment and everyday decision-making intersect. With 50% of FAST viewers consuming content on their PCs, we are excited to help HP build a more direct pathway for advertisers to engage active users across every stage of their digital journey.”

“Scaling HP Media Network and HP TV+ requires technology that can support the complexity of video advertising while giving advertisers more flexible ways to access our banner and video inventory,” said Chris Ryu, General Manager of HP Media Network. “Magnite brings together the ad serving and programmatic capabilities we need to support that growth, giving HP TV+ a more integrated foundation as we expand our streaming advertising business.”

About Magnite
We’re Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising company. Publishers use our technology to monetize their content across all screens and formats including CTV, online video, display, and audio. The world’s leading agencies and brands trust our platform to access brand-safe, high-quality ad inventory and execute billions of advertising transactions each month. Anchored in bustling New York City, sunny Los Angeles, mile high Denver, historic London, colorful Singapore, and down under in Sydney, Magnite has offices across North America, EMEA, LATAM, and APAC.

Media Contact:
Charlstie Veith
cveith@magnite.com

Investor Contact:
Nick Kormeluk
nkormeluk@magnite.com

LONDON and NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the appointment of Alan M. Sebulsky to its Board of Directors.

Mr. Sebulsky is a veteran healthcare portfolio manager and biopharmaceutical investment analyst with more than 40 years of experience in public company investment, financial strategy, portfolio evaluation and growth, and board leadership. Mr. Sebulsky most recently served as Partner and Portfolio Manager at Adage Capital Management for the past 14 years, where he led a team overseeing a diversified biopharmaceutical portfolio with over $2 billion in assets. Prior to this, he founded Apothecary Capital, an asset management firm focused on investments across the healthcare and biopharmaceutical sectors. He reestablished Apothecary in April 2026 and currently serves as the Managing Member.

Mr. Sebulsky currently serves on the Board of Directors of Parabilis Medicines, Inc. and previously served on the Boards of Directors and Audit Committees for both Jazz Pharmaceuticals and Arrow International, two publicly traded healthcare companies, and on the boards of three private healthcare companies in which Apothecary Capital invested. In these roles, he worked closely with company leadership to advance portfolio, commercial and business strategy.

Mr. Sebulsky holds an M.S. in finance and a B.B.A. in finance and economics from the University of Wisconsin–Madison.

“We are delighted to welcome Alan to our Board of Directors,” said Alexandria Forbes, Ph.D., president and chief executive officer of MeiraGTx. “I have known Alan for 25 years and I have always had the highest respect for him both professionally and personally. His decades of investing in and working with biopharmaceutical companies brings a valuable perspective to the board which is particularly important as we continue to transform MeiraGTx into a commercial company.”

Keith Harris, Chairman of the Board of Directors of MeiraGTx, added, “I am pleased that Alan is joining our board. He brings an extensive wealth of knowledge of our sector and public company experience. We look forward to his invaluable assistance in helping the further growth of our Company.”

About MeiraGTx

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline with four late-stage clinical programs. Each of these programs use local delivery of small doses resulting in disease modifying effects in both inherited and more common diseases, in the eye, radiation-induced xerostomia, and Parkinson’s disease. MeiraGTx uses its innovative technology in optimization of capsids, promoters and novel translational control elements to develop best in class, potent, safe viral vectors. MeiraGTx’s broad pipeline is supported by end-to-end in-house manufacturing. MeiraGTx has built the most comprehensive manufacturing capabilities in the industry, including two that are licensed for GMP viral vector production and a GMP QC facility with clinical and commercial licensure. In addition, MeiraGTx has developed a proprietary manufacturing platform process over 10 years based on more than 20 different viral vectors with leading yield and quality aspects and commercial readiness. Uniquely, MeiraGTx has developed a novel technology for in vivo delivery of any biologic therapeutic using oral small molecules. This transformative riboswitch gene regulation technology allows precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing the riboswitch platform on the regulated in vivo delivery of metabolic peptides, including GLP-1, GIP, Glucagon, Amylin, PYY and Leptin, as well as cell therapy, CAR-T for liquid and solid tumors and autoimmune diseases, and additionally PNS targets addressing long term intractable pain. MeiraGTx has developed the technology to apply genetic medicine to common diseases, increasing efficacy, addressing novel targets, and expanding access in some of the largest disease areas where the unmet need remains high.

For more information, please visit www.meiragtx.com.

Contacts

Investors:
MeiraGTx
Investors@meiragtx.com

or

Media:
Jordyn Temperato
LifeSci Communications
jtemperato@lifescicomms.com

GAITHERSBURG, Md., Sept. 23, 2026 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate in a fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum on Wednesday, September 30, 2026, at 10:30 a.m. ET.

A webcast of the fireside chat will be available via the Events section of the Altimmune website.

About Altimmune
Altimmune is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company’s lead candidate, pemvidutide, is a unique dual-action investigational therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on X

Investor Contact:
Luis Sanay, CFA
Vice President, Investor Relations
ir@altimmune.com

Media Contact:
Real Chemistry
altimmune@realchemistry.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.